Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Sisram Medical to Report H1 2024 Financial Results on August 21 and Hold a Conference Call on August 22 2024-08-15 09:00
Ivonescimab (PD-1/VEGF) Received Priority Review from China's NMPA for First-Line Treatment of PD-L1 Positive NSCLC 2024-08-15 07:30
REMOVERY TO PROVIDE 150 FREE TATTOO REMOVAL PACKAGES TO COMMEMORATE THE INAUGURAL WORLD TATTOO REMOVAL DAY 2024-08-14 22:13
Strategic Partnership Between Beyond Medical Group (Singapore) and SingMed Medical Centre (Cambodia) Enhances Healthcare Collaboration 2024-08-14 12:39
Novo AI to Cut Costs and Boost Efficiency For Insurance Companies 2024-08-14 08:30
LBB Specialties Expands into Puerto Rico and Latin America to Serve Growing Life Sciences Market 2024-08-13 23:00
Public Interest Registry Announces 2024 .ORG Impact Awards Finalists, Emmy & Tony Award Winner Alan Cumming to Host 2024-08-13 22:00
AWESum Care welcomes Mr. John Tsang as its first ambassador 2024-08-13 21:18
Alfred Health Enhances Cancer Patient Care with Oracle Health 2024-08-13 21:00
Qilian International Holding Group Ltd. Announces Trading Ticker Symbol to "BGM" 2024-08-13 20:00
Sinch AI Used to Safely Pre-Triage Patients 2024-08-13 15:51
Docquity Drives Demand for SIT Pharma's Duo Probiotics in Thailand, Achieving 31% Sales Growth in 6 months 2024-08-13 10:00
Registrational Phase III Study of Lisaftoclax in Newly-Diagnosed Patients with Higher-Risk Myelodysplastic Syndrome Cleared by China CDE 2024-08-13 09:52
Chang Gung Cancer Proton Therapy Achieves Breakthrough 2024-08-13 09:03
Biosyngen's BRG01 Receives FDA Approval for Phase II Clinical Trial 2024-08-13 09:00
Pantai Hospital Kuala Lumpur Introduces Outpatient Parenteral Antimicrobial Therapy (OPAT) for Improved Patient Care 2024-08-13 08:53
AI in the IVF Process is the Standard of Care at Virtus Fertility Centre Singapore 2024-08-13 08:44
MediPortal Introduces AI for Practice Management in Australia 2024-08-13 08:30
Lynk Pharmaceuticals Announces Positive Results from Phase 1b Clinical Study of LNK01004 for the Treatment of Atopic Dermatitis 2024-08-13 08:00
Celltrion USA announces incorporation of adalimumab-aaty, a Humira® biosimilar, to the Costco Member Prescription Program 2024-08-13 07:46
1 49 50 51 52 53 1596